Showing results (21-30 of 36) with videos related to
Sort By:
Pageof 4
Plos One|October 29, 2014
Src mutation induces acquired lapatinib resistance in ERBB2-amplified human gastroesophageal adenocarcinoma modelsYong Sang Hong, Jihun Kim, Eirini Pectasides, et al.Cancer Immunology Research|June 18, 2015
Epithelial PD-L2 Expression Marks Barrett's Esophagus and Esophageal AdenocarcinomaSarah Derks, Katie S Nason, Xiaoyun Liao, et al.Immunity|December 3, 2013
Neonatal Fc receptor expression in dendritic cells mediates protective immunity against colorectal cancerKristi Baker, Timo Rath, Magdalena B Flak, et al.Gastroenterology|April 3, 2018
Detection of Mutations in Barrett's Esophagus Before Progression to High-Grade Dysplasia or AdenocarcinomaMatthew D Stachler, Nicholas D Camarda, Christopher Deitrick, et al.Nature Genetics|February 7, 2020
Early TP53 alterations engage environmental exposures to promote gastric premalignancy in an integrative mouse modelNilay S Sethi, Osamu Kikuchi, Gina N Duronio, et al.Nature Communications|October 4, 2023
Genomic signatures of past and present chromosomal instability in Barrett's esophagus and early esophageal adenocarcinomaChunyang Bao, Richard W Tourdot, Gregory J Brunette, et al.Science Translational Medicine|April 16, 2025
Expansion of a bacterial operon during cancer treatment ameliorates fluoropyrimidine toxicityKai R Trepka, Wesley A Kidder, Than S Kyaw, et al.Biorxiv : the Preprint Server for Biology|June 19, 2024
Expansion of a bacterial operon during cancer treatment ameliorates drug toxicityKai R Trepka, Wesley A Kidder, Than S Kyaw, et al.The Oncologist|June 22, 2024
HER2 overexpression in urothelial carcinoma with GATA3 and PPARG copy number gainsXiaolin Zhu, Emily Chan, Michelle L Turski, et al.Clinical and Translational Gastroenterology|July 15, 2024
Molecular Analysis of Persistent and Recurrent Barrett's Esophagus in the Setting of Endoscopic TherapyAarti Kumar, Marianne Rara, Ming Yu, et al.Pageof 4